Hap Trading, LLC Kodiak Sciences Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	SELL	$5.04 - $9.48 $64,512 - $121,344	-12,800 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$7.09 - $89.45 $90,752 - $1.14 Million	12,800 New	12,800 $1,000
Q1 2021 May 14, 2021	SELL	$110.45 - $164.47 $5 Million - $7.45 Million	-45,300 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $2.75 Million - $6.98 Million	45,300 New	45,300 $731,000
Q2 2020 Aug 10, 2020	SELL	$42.74 - $66.25 $547,072 - $848,000	-12,800 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$38.18 - $73.95 $656,696 - $1.27 Million	-17,200 Reduced 57.33%	12,800 $15,000
Q4 2019 Feb 11, 2020	BUY	$13.9 - $76.65 $417,000 - $2.3 Million	30,000 New	30,000 $218,000

104

39.8M

7.6K

3.5K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $138M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.